Human TREM2/PLOSL2/TREM-2 ORF/cDNA clone-Adeno-associate virus(AAV) plasmid (NM_018965.4)
Cat. No.: pGMAAV000622
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human TREM2/PLOSL2/TREM-2 Adeno-associated virus expression plasmid (ITR-vector) for TREM2 AAV packaging, TREM2 AAV production.The purified Human TREM2/PLOSL2/TREM-2 AAV particle serves as an invaluable asset for in-depth in vivo TREM2 studies, mechanism of action (MOA) research, and the evolution of TREM2-associated gene therapy strategies.
Our GM-AAV ITR vector is optimized with the G-NEXT™ multi-serotypes AAV vector system. Explore the G-NEXT™ system in detail.
Go to
TREM2/PLOSL2 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
Catalog ID | pGMAAV000622 |
Gene Name | TREM2 |
Accession Number | NM_018965.4 |
Gene ID | 54209 |
Species | Human |
Product Type | Adeno-associate virus(AAV) plasmid (overexpression) |
Insert Length | 693 bp |
Gene Alias | PLOSL2,TREM-2,Trem2a,Trem2b,Trem2c |
Fluorescent Reporter | ZsGreen |
Mammalian Cell Selection | Null |
Fusion Tag | MYC (C-Terminal) |
Promoter | CD68 |
Resistance | Amplicin |
ORF Nucleotide Sequence | ATGGAGCCTCTCCGGCTGCTCATCTTACTCTTTGTCACAGAGCTGTCCGGAGCCCACAACACCACAGTGTTCCAGGGCGTGGCGGGCCAGTCCCTGCAGGTGTCTTGCCCCTATGACTCCATGAAGCACTGGGGGAGGCGCAAGGCCTGGTGCCGCCAGCTGGGAGAGAAGGGCCCATGCCAGCGTGTGGTCAGCACGCACAACTTGTGGCTGCTGTCCTTCCTGAGGAGGTGGAATGGGAGCACAGCCATCACAGACGATACCCTGGGTGGCACTCTCACCATTACGCTGCGGAATCTACAACCCCATGATGCGGGTCTCTACCAGTGCCAGAGCCTCCATGGCAGTGAGGCTGACACCCTCAGGAAGGTCCTGGTGGAGGTGCTGGCAGACCCCCTGGATCACCGGGATGCTGGAGATCTCTGGTTCCCCGGGGAGTCTGAGAGCTTCGAGGATGCCCATGTGGAGCACAGCATCTCCAGGAGCCTCTTGGAAGGAGAAATCCCCTTCCCACCCACTTCCATCCTTCTCCTCCTGGCCTGCATCTTTCTCATCAAGATTCTAGCAGCCAGCGCCCTCTGGGCTGCAGCCTGGCATGGACAGAAGCCAGGGACACATCCACCCAGTGAACTGGACTGTGGCCATGACCCAGGGTATCAGCTCCAAACTCTGCCAGGGCTGAGAGACACGTGA |
ORF Protein Sequence | MEPLRLLILLFVTELSGAHNTTVFQGVAGQSLQVSCPYDSMKHWGRRKAWCRQLGEKGPCQRVVSTHNLWLLSFLRRWNGSTAITDDTLGGTLTITLRNLQPHDAGLYQCQSLHGSEADTLRKVLVEVLADPLDHRDAGDLWFPGESESFEDAHVEHSISRSLLEGEIPFPPTSILLLLACIFLIKILAASALWAAAWHGQKPGTHPPSELDCGHDPGYQLQTLPGLRDT |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
---|---|---|
Target Antibody | GM-Tg-g-T45086-Ab | Anti-TREM2/ TREM-2/ Trem2a monoclonal antibody |
Target Antigen | GM-Tg-g-T45086-Ag | TREM2 VLP (virus-like particle) |
ORF Viral Vector | pGMLP003467 | Human TREM2 Lentivirus plasmid |
ORF Viral Vector | pGMAAV000622 | Human TREM2 Adeno-associate virus(AAV) plasmid |
ORF Viral Vector | vGMLP003467 | Human TREM2 Lentivirus particle |
ORF Viral Vector | vGMAAV000622 | Human TREM2 Adeno-associate virus(AAV) particle |
Target information
Target ID | GM-T45086 |
Target Name | TREM2 |
Gene ID | 54209, 83433, 719740, 301227, 101099297, 119863908, 506467, 100066180 |
Gene Symbol and Synonyms | LOC119863908,PLOSL2,TREM-2,TREM2,Trem2-Mia,Trem2-Mib,Trem2a,Trem2b,Trem2c |
Uniprot Accession | Q9NZC2 |
Uniprot Entry Name | TREM2_HUMAN |
Protein Sub-location | Transmembrane Protein |
Category | Therapeutics Target |
Disease | Not Available |
Gene Ensembl | ENSG00000095970 |
Target Classification | Not Available |
This gene encodes a membrane protein that forms a receptor signaling complex with the TYRO protein tyrosine kinase binding protein. The encoded protein functions in immune response and may be involved in chronic inflammation by triggering the production of constitutive inflammatory cytokines. Defects in this gene are a cause of polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Nov 2012]
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.